| 摘要 |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention refers to chemical-pharmaceutical industry, concerns a pharmaceutical composition for treating sexual and premenstrual disorders containing flibanserin 1, as one active substance in a combination with at least another one active substance 2 specified in a group consisting of melanokortin agonists, prostaglandin E1 agonists increasing the level of cyclic guanosine-3',5'-monophosphate (cGMP) agent (preferentially PDE V inhibitors), 5-HT1A agonists, dopamine agonists, 5-HT2A/C antagonists, selective androgen receptor modulators (SARM), selective oestrogen receptor modulators (SORM), oestrogens, androgens and -adrenoreceptor antagonists. Also, the invention concerns a method of treating sexual and premenstrual disorders. ^ EFFECT: composition shows high efficacy. ^ 27 cl, 10 ex |
